Cargando…
Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
Utilizing the host immune system to eradicate cancer cells has been the most investigated subject in the cancer research field in recent years. However, most of the studies have focused on highly variable responses from immunotherapies such as immune checkpoint inhibitors, from which the majority of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834780/ https://www.ncbi.nlm.nih.gov/pubmed/29288513 http://dx.doi.org/10.1111/cas.13498 |